Also interested in the contents of the Cardio protective anti cancer combinations patent filed by them in late October last year.
it seems the one single document/signature whatever it is holding everything up had to start again from the bottom of the pile.Tough hold right now, can’t buy more until I can see some clinical traction. I don’t see how dosing this qtr is possible unless governance can be done while we wait for ethics formalities? Given how linear and ‘clinical’ the process is I’d say not. Maybe we’ll be surprised? But so far the hospital seems to be the slower cog in the works.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.34 |
Change
-0.015(1.11%) |
Mkt cap ! $231.9M | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.36 | $1.31 | $132.3K | 98.59K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | $1.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.34 | 10069 | 2 |
View Market Depth
| Last trade - 15.54pm 20/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |